146 related articles for article (PubMed ID: 29893708)
1. Rapamycin Combi with TAE on the Growth, Metastasis, and Prognosis of Hepatocellular Carcinoma in Rat Models.
Lei HW; Cai J; Li CM; Yang F; Shi WQ; Shi WQ; Wang LP; Feng YY
Ann Hepatol; 2018 July - August ,; 17(4):645-654. PubMed ID: 29893708
[TBL] [Abstract][Full Text] [Related]
2. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
[TBL] [Abstract][Full Text] [Related]
3. Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma.
Wang GZ; Fang ZT; Zhang W; Qu XD; Qian S; Liu R; Wang JH
Oncol Rep; 2014 Jan; 31(1):95-102. PubMed ID: 24173823
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
[TBL] [Abstract][Full Text] [Related]
5. A Combination of UTMD-Mediated HIF-1
Liao Y; Luo H; He Z; Kuang Y; Chen P; Zhang X; Chen J; Wen Q; Xie Y; Ding S
Biomed Res Int; 2019; 2019():1937460. PubMed ID: 30911540
[TBL] [Abstract][Full Text] [Related]
6. Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats.
Sun X; Jiang H; Jiang X; Tan H; Meng Q; Sun B; Xu R; Krissansen GW
Hum Gene Ther; 2009 Apr; 20(4):314-24. PubMed ID: 19327024
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.
Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS
J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445
[TBL] [Abstract][Full Text] [Related]
8. RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors.
Chen C; Wang J; Liu R; Qian S
Tumour Biol; 2012 Aug; 33(4):1095-103. PubMed ID: 22407533
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.
Liao XF; Yi JL; Li XR; Deng W; Yang ZF; Tian G
World J Gastroenterol; 2004 Jul; 10(13):1885-9. PubMed ID: 15222029
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
Wang GZ; Zhang W; Fang ZT; Zhang W; Yang MJ; Yang GW; Li S; Zhu L; Wang LL; Zhang WS; Liu R; Qian S; Wang JH; Qu XD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1125-36. PubMed ID: 24756364
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells.
Chen W; Hu QD; Xia XF; Liang C; Liu H; Zhang Q; Ma T; Liang F; Liang TB
Cancer Biol Ther; 2014 Aug; 15(8):992-9. PubMed ID: 24800850
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
15. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.
Wang W; Jia WD; Xu GL; Wang ZH; Li JS; Ma JL; Ge YS; Xie SX; Yu JH
Dig Dis Sci; 2009 Oct; 54(10):2128-36. PubMed ID: 19052864
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts.
Tong H; Li X; Zhang CL; Gao JH; Wen SL; Huang ZY; Wen FQ; Fu P; Tang CW
J Dig Dis; 2013 Jan; 14(1):29-37. PubMed ID: 23134145
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
